Bromocriptine Mesylate Tablet
Product Images NDC 60687-931

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 60687-931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2.5 mg Bromocriptine Mesylate Tablet Blister.jpg (2.5 mg Bromocriptine Mesylate Tablet Blister.jpg)

FDA Label Image

2.5 mg Bromocriptine Mesylate Tablets Carton.jpg (2.5 mg Bromocriptine Mesylate Tablets Carton.jpg)

This description provides information about bromocriptine mesylate tablets, which come in a package with NDC code 60687-931-21. Each tablet contains 25mg of Bromocriptine Mesylate, and the usual dosage is to refer to the prescribing information. The tablets are to be stored at 20-25°C (68-77°F) with excursions permitted between 15-30°C (56-86°F). The package is distributed by American Health Packaging and may include products from ANI Pharmaceuticals. Additionally, the package contains 30 tablets (3 x 10) for oral use only, and there is a caution not to use if the seal is broken.*

FDA Label Image

Structure (Structure)

This is not-available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.